Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease

Jared W Benedict1, Crosby A Sommers, David A Pearce

  • 1Center for Aging and Developmental Biology, Aab Institute of Biomedical Sciences, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

Insights

Juvenile Batten disease shows increased oxidative damage in the brain, particularly in the cerebellum. This neurodegeneration is linked to reduced glutathione and increased protein oxidation, highlighting oxidative stress in this childhood disorder.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Oxidative damage contributes to neurodegenerative disease pathogenesis.
  • Juvenile Batten disease, caused by Cln3 mutations, is a childhood neurodegenerative disorder.

Purpose of the Study:

  • To characterize oxidative stress in the central nervous system (CNS) of a Cln3(-/-) mouse model of juvenile Batten disease.
  • To identify specific brain regions affected by oxidative damage and alterations in antioxidant defenses.

Main Methods:

  • Comparative analysis of oxidative markers (glutathione, protein oxidation) across CNS regions.
  • Measurement of antioxidant enzyme levels, specifically manganese superoxide dismutase (MnSOD).
  • Immunohistochemical colocalization studies to identify cellular sources of oxidative stress.

Main Results:

  • Reduced total glutathione observed in the cerebellum of Cln3(-/-) mice.
  • Increased protein oxidation detected in the cerebellum, thalamus, and primary motor cortex.
  • Elevated MnSOD levels in the thalamus, potentially indicating a response to superoxide radicals; microglia found near MnSOD-expressing neurons.

Conclusions:

  • The study provides initial neuroanatomical insights into oxidative damage in juvenile Batten disease.
  • Loss of CLN3 function leads to specific oxidative burdens in distinct CNS regions.
  • Microglial activation may play a role in the observed oxidative damage and disease progression.